While previous studies have shown that mTOR inhibitors can cause interstitial pneumonitis, we also included COPD and pulmonary hypertension due to the theoretical risk that other pulmonary toxicity may be present. This evidence concerns the gene MTOR and chronic obstructive pulmonary disease.